BMAL1 and dilated cardiomyopathy: In human embryonic stem cell-derived cardiomyocytes, loss of BMAL1 inhibits mitochondrial fission and mitophagy, impairs oxidative metabolism, and leads to disorganized sarcolemmal structure, decreased contractility, and dilated cardiomyopathy (Li E. et al., 2020).